✦ LIBER ✦

Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders

✍ Scribed by L. Beretta; M. Caronni; M. Vanoli; R. Scorza

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 903 KB
Volume: 147
Category: Article
ISSN: 0007-0963
DOI: 10.1046/j.1365-2133.2002.48901.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of systemic lupus erythemato

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

✍ Paul J. Schilling; Razelle Kurzrock; Hagop Kantarjian; Jordan U. Gutterman; Mosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

Overlap syndrome of polymyositis and pro

Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C

✍ Otsuka, Takeshi ;Sakamoto, Noriko ;Tanaka, Yosuke ;Yamaoka, Kunihiro ;Nakashima, 📂 Article 📅 1999 🏛 Informa UK (Informa Healthcare) 🌐 English ⚖ 793 KB

Expression of transforming growth factor

Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B

✍ Dr Yosuke Morimitsu; David E. Kleiner Jr.; Hari S. Conjeevaram; Chu Chieh Hsia; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

The effect of interferon alfa (IFN-a) therapy on the expression of transforming growth factor alpha (TGF-a) in the liver during chronic hepatitis B was investigated. Serial liver biopsy specimens were evaluated from 35 patients who had participated in a randomized, controlled trial of recombinant hu

A phase II trial of pegylated interferon

A phase II trial of pegylated interferon α-2b therapy for polycythemia vera and essential thrombocythemia : Feasibility, clinical and biologic effects, and impact on quality of life

✍ Jan Samuelsson; Hans Hasselbalch; Oystein Bruserud; Snezana Temerinac; Yvonne Br 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB